Breaking News Instant updates and real-time market news.

PSO

Pearson

$11.10

0.14 (1.28%)

, LITE

Lumentum

$53.46

1.41 (2.71%)

10:03
03/22/19
03/22
10:03
03/22/19
10:03

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Pearson (PSO) upgraded to Overweight from Neutral at JPMorgan with analyst Daniel Kerven saying the company's business model is improving as its moves from print to digital. 2. Lumentum (LITE) upgraded to Overweight from Neutral at JPMorgan with analyst Samik Chatterjee seeing a "solid" outlook for the company's telecom business amid "strong" growth led by 5G investments and upside to synergy targets relative to recent acquisition of Oclaro. 3. Best Buy (BBY) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Nagel stating the company has undergone a significant transformation under the direction of new senior leadership to one of retail's preeminent omnichannel operators. 4. Varian Medical (VAR) upgraded to Outperform from Neutral at Baird with analyst Jason Bednar saying that with near-term trends sounding healthy, multiple paths are emerging for Varian to sustain upper-single digit plus oncology order growth, and low- to mid-teens EPS growth. 5. Chipotle (CMG) upgraded to Neutral from Underperform at Wedbush with analyst Nick Setyan noting he no longer sees risk to near- and medium-term same-store sales growth and unit-level margin expectations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

PSO

Pearson

$11.10

0.14 (1.28%)

LITE

Lumentum

$53.46

1.41 (2.71%)

BBY

Best Buy

$72.35

1.79 (2.54%)

VAR

Varian Medical

$141.26

3.49 (2.53%)

CMG

Chipotle

$676.46

6.59 (0.98%)

  • 24

    Apr

  • 24

    Apr

  • 28

    May

PSO Pearson
$11.10

0.14 (1.28%)

07/05/18
SOCG
07/05/18
DOWNGRADE
SOCG
Hold
Pearson downgraded to Hold from Buy at Societe Generale
03/07/19
UBSW
03/07/19
INITIATION
UBSW
Neutral
Pearson initiated with a Neutral at UBS
UBS analyst Adam Berlin started Pearson with a Neutral saying the upside/downside ratio is balanced at current share levels.
08/01/18
SBSH
08/01/18
DOWNGRADE
SBSH
Neutral
Pearson downgraded to Neutral from Buy at Citi
Citi downgraded Pearson to Neutral saying the risk/reward is more balanced over the near-term. The firm keeps a price target of 975p for the shares.
03/22/19
JPMS
03/22/19
UPGRADE
JPMS
Overweight
Pearson upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Daniel Kerven upgraded Pearson to Overweight from Neutral and raised his price target for the shares to GBP 10.50 from GBP 8.50. The company's business model is improving as its moves from print to digital, Kerven tells investors in a research note. He increased his longer term estimates on Pearson's return to higher education growth.
LITE Lumentum
$53.46

1.41 (2.71%)

02/06/19
MKMP
02/06/19
NO CHANGE
Target $66
MKMP
Buy
Lumentum price target raised to $66 from $60 at MKM Partners
MKM Partners analyst Michael Genovese raised his price target on Lumentum to $66 and kept his Buy rating after its Q3 results. The analyst says that while earnings missed by a penny, the global ROADM, or reconfigurable optical add-drop multiplexer, demand in U.S. and Europe remains strong, with added momentum coming from the build-out of the Metro networks in China. Genovese contends that Lumentum has "at least a couple more quarters of growth" with no meaningful inventory build happening in ROADMs.
01/24/19
PIPR
01/24/19
NO CHANGE
Target $59
PIPR
Overweight
Lumentum price target lowered to $59 from $63 at Piper Jaffray
Piper Jaffray analyst Troy Jensen reduced his 3D sensing and earnings estimates for Lumentum but believes this is already factored into the company's current valuation and should not be a surprise to investors. The analyst continues to view Lumentum as one of the better positioned optical component suppliers and believes its acquisition of Oclaro strengthens the company's position and should lead to industry-leading profitability as cost synergies materialize. As such, despite lowering his price target for the shares to $59 from $63, Jensen reiterates an Overweight rating on Lumentum. The company can grow its 3D sensing segment from "these depressed levels" and show accelerating growth in 2019 and beyond, the analyst tells investors in a research note.
03/22/19
JPMS
03/22/19
UPGRADE
Target $65
JPMS
Overweight
JPMorgan upgrades Lumentum to Overweight on iPhone volume stabilization
JPMorgan analyst Samik Chatterjee upgraded Lumentum Holdings (LITE) to Overweight from Neutral and raised his price target for the shares to $65 from $50. The stock closed yesterday up $2.44, of 5%, to $52.10. The analyst sees a "solid" outlook for the company's telecom business amid "strong" growth led by 5G investments and upside to synergy targets relative to recent acquisition of Oclaro. Further, he sees limited downside risk relative to volume expectations for Apple's (AAPL) iPhone, which he notes has been a "key driver of sentiment on the shares." Stabilization of its iPhone volume outlook should drive focus back to the "strong" fundamentals in Lumentum's primary telecom business, Chatterjee tells investors in a research note.
03/22/19
JPMS
03/22/19
UPGRADE
Target $65
JPMS
Overweight
Lumentum upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Samik Chatterjee upgraded Lumentum Holdings to Overweight from Neutral and raised his price target for the shares to $65 from $50.
BBY Best Buy
$72.35

1.79 (2.54%)

03/22/19
OPCO
03/22/19
UPGRADE
OPCO
Outperform
Best Buy upgraded to Outperform from Perform at Oppenheimer
03/20/19
EVER
03/20/19
INITIATION
Target $75
EVER
In Line
Best Buy initiated with an In Line at Evercore ISI
Evercore ISI analyst Greg Melich started Best Buy with an In Line rating and $75 base case price target, stating that he assumes comps normalize in the low single digits in 2019 and 2020 and that margins will "slip modestly."
03/22/19
OPCO
03/22/19
UPGRADE
Target $86
OPCO
Outperform
Best Buy well positioned against healthy spending backdrop, says Oppenheimer
Oppenheimer analyst Brian Nagel upgraded Best Buy to Outperform from Perform with an $86 price target. In a research note to investors, Nagel says Best Buy has undergone a significant transformation under the direction of new senior leadership to one of retail's preeminent omnichannel operators, and says the market narrative on Best Buy is now more upbeat. Nagel says Best Buy is well positioned against a healthy spending backdrop, but feels investors are still not fully embracing improved sales and EPS power.
03/07/19
LOOP
03/07/19
NO CHANGE
Target $88
LOOP
Buy
Best Buy prices 'remain very competitive with Amazon', says Loop Capital
Loop Capital analyst Anthony Chukumba kept his Buy rating and $88 price target on Best Buy (BBY), saying his survey of identical products sold on Amazon (AMZN) suggest that pricing remains "very competitive". Across 50 compared items, the average price gap has narrowed to 2.1% from 2.4% in his last survey in December, the analyst tells investors. Chukumba further sees Best Buy as the "last man standing" among the dedicated national consumer electronics retailer and also believes that it can benefit from the "forthcoming 5G wireless technology wave."
VAR Varian Medical
$141.26

3.49 (2.53%)

03/22/19
BARD
03/22/19
UPGRADE
BARD
Outperform
Varian Medical upgraded to Outperform from Neutral at Baird
03/22/19
BARD
03/22/19
UPGRADE
Target $162
BARD
Outperform
Varian Medical upgraded to Outperform from Neutral at Baird
Baird analyst Jason Bednar upgraded Varian Medical to Outperform from Neutral and raised his price target to $162 from $127. In a research note to investors, Bednar says that with near-term trends sounding healthy, multiple paths are emerging for Varian to sustain upper-single digit plus oncology order growth, and low- to mid-teens EPS growth looking increasingly likely and sustainable into fiscal 2020 and beyond, he believes Varian is quickly becoming a premium medech grower and a stock that investors can consider a core medtech holding.
01/24/19
JEFF
01/24/19
NO CHANGE
Target $145
JEFF
Buy
Varian Medical price target raised to $145 from $125 at Jefferies
Jefferies analyst Anthony Petrone raised his price target for Varian Medical to $145 saying the company posted a beat for fiscal Q1 despite an impact from tariffs. The analyst believes the company can sustain order growth in low-teens at least through fiscal 2020 and keeps a Buy rating on the shares.
01/24/19
RBCM
01/24/19
NO CHANGE
Target $130
RBCM
Sector Perform
Varian Medical price target raised to $130 from $115 at RBC Capital
RBC Capital analyst Brandon Henry raised his price target on Varian Medical to $130 after its Q1 results, saying the company's "gross order outperformance" was geographically broad. The analyst also contends that the company is "benefiting from a strong new product portfolio and what appears to be a continued acceleration in radiation oncology market growth." Henry keeps his Sector Perform rating on the shares however, noting that the medium term trend in the worldwide radiation oncology market is "difficult to forecast."
CMG Chipotle
$676.46

6.59 (0.98%)

03/22/19
WEDB
03/22/19
UPGRADE
WEDB
Neutral
Chipotle upgraded to Neutral from Underperform at Wedbush
03/21/19
ARGS
03/21/19
NO CHANGE
Target $770
ARGS
Buy
Chipotle price target raised to $770 from $670 at Argus
Argus analyst John Staszak raised his price target on Chipotle to $770 and kept his Buy rating, also raising his FY19 and FY20 EPS view by 10c and 70c respectively to $12.60 and $15.70. The analyst cites the company's efforts in re-establishing its strong brand that was previously hurt by food safety issues and to improve customer experience through online ordering and mobile payments. Staszak also contends that the market is not sufficiently valuing Chipotle's prospects for accelerating same-store sales and earnings growth.
03/18/19
PIPR
03/18/19
NO CHANGE
Target $725
PIPR
Overweight
Chipotle price target raised to $725 from $661 at Piper Jaffray
Piper Jaffray analyst Nicole Miller Regan raised her price target for Chipotle Mexican Grill to $725 from $661 after analyzing a hypothetical transformation of the company's international business into a "franchised growth vehicle." The stock closed Friday down $2.96 to $639.00. The analyst believes in the long-term case for franchising but also acknowledges the company has not publicly identified this as an initiative and, as such, expects "much work remains to be accomplished." However, such a transformation could help to "unlock incremental profitability" of $2 to $5 in earnings power per share, drive upside to global growth, and potentially set up Chipotle shares for "some measure of multiple expansion as the company becomes incrementally asset-light, over time," Regan tells investors in a research note. Chipotle remains her "top recovery investment recommendation." The analyst has a "high-degree of conviction" that its current strategic initiatives can continue to generate improving fundamentals. Regan keeps an Overweight rating on the name.
03/22/19
WEDB
03/22/19
UPGRADE
Target $640
WEDB
Neutral
Chipotle upgraded to Neutral from Underperform at Wedbush
Wedbush analyst Nick Setyan upgraded Chipotle Mexican Grill to Neutral from Underperform and raised his price target to $640 from $500, telling investors in a research note that he no longer sees risk to near- and medium-term same-store sales growth and unit-level margin expectations.

TODAY'S FREE FLY STORIES

01:55
09/23/19
09/23
01:55
09/23/19
01:55
General news
FX Action: »

FX Action: Soothing tones…

01:55
09/23/19
09/23
01:55
09/23/19
01:55
General news
Fedspeak preview: »

Fedspeak preview:…

01:45
09/23/19
09/23
01:45
09/23/19
01:45
General news
Mideast tensions keep oil prices underpinned. »

Mideast tensions keep oil…

01:30
09/23/19
09/23
01:30
09/23/19
01:30
General news
Asian Market Wrap: »

Asian Market Wrap: Asian…

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

19:35
09/22/19
09/22
19:35
09/22/19
19:35
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

DB

Deutsche Bank

$7.99

-0.08 (-0.99%)

BNPQY

BNP Paribas

$0.00

(0.00%)

JNJ

Johnson & Johnson

$131.73

1.75 (1.35%)

TEVA

Teva

$7.44

-0.08 (-1.06%)

ENDP

Endo

$3.48

0.115 (3.42%)

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

ABT

Abbott

$83.56

0.35 (0.42%)

AMRX

Amneal Pharmaceuticals

$3.34

0.21 (6.71%)

MYL

Mylan

$21.01

0.03 (0.14%)

MCK

McKesson

$146.83

1.06 (0.73%)

CAH

Cardinal Health

$47.89

-0.14 (-0.29%)

ABC

AmerisourceBergen

$85.13

0.475 (0.56%)

WAB

Wabtec

$74.01

0.26 (0.35%)

CVS

CVS Health

$64.28

0.65 (1.02%)

REAL

RealReal

$17.00

0.21 (1.25%)

CMG

Chipotle

$835.17

3.67 (0.44%)

MCD

McDonald's

$209.44

-1.12 (-0.53%)

YUM

Yum! Brands

$112.31

-1.83 (-1.60%)

WEN

Wendy's

$20.77

0.22 (1.07%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

DAL

Delta Air Lines

$58.63

-0.05 (-0.09%)

FANG

Diamondback Energy

$96.90

-0.45 (-0.46%)

EHC

Encompass Health

$64.41

-0.01 (-0.02%)

FB

Facebook

$189.88

-0.27 (-0.14%)

MSFT

Microsoft

$139.34

-1.74 (-1.23%)

PG

Procter & Gamble

$122.22

0.37 (0.30%)

KO

Coca-Cola

$53.90

-0.62 (-1.14%)

PEP

PepsiCo

$134.49

-0.98 (-0.72%)

CL

Colgate-Palmolive

$70.97

0.01 (0.01%)

KMB

Kimberly-Clark

$135.13

0.9 (0.67%)

K

Kellogg

$63.79

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 01

    Oct

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 03

    Oct

  • 08

    Oct

  • 10

    Oct

  • 15

    Oct

  • 16

    Oct

  • 18

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 01

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

BGNE

BeiGene

$135.62

2.61 (1.96%)

19:34
09/22/19
09/22
19:34
09/22/19
19:34
Hot Stocks
BeiGene announces results on Tislelizumab from ongoing clinical trials »

BeiGene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 15

    Oct

  • 27

    Feb

CE

Celanese

$122.73

-1.06 (-0.86%)

19:24
09/22/19
09/22
19:24
09/22/19
19:24
Hot Stocks
Celanese experiences emergency incident at Clear Lake facility »

Celanese experienced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$379.33

-5.28 (-1.37%)

19:21
09/22/19
09/22
19:21
09/22/19
19:21
Periodicals
Indonesia to fault 737 Max design, oversight lapses in Lion Air crash, WSJ says »

Indonesian investigators…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

AA

Alcoa

$21.70

-0.26 (-1.18%)

19:15
09/22/19
09/22
19:15
09/22/19
19:15
Downgrade
Alcoa rating change at Goldman Sachs »

Alcoa downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

AA

Alcoa

$21.70

-0.26 (-1.18%)

, SCHN

Schnitzer Steel

$23.55

-0.27 (-1.13%)

19:15
09/22/19
09/22
19:15
09/22/19
19:15
Downgrade
Alcoa downgraded to Neutral from Buy at Goldman Sachs »

Goldman Sachs analyst…

AA

Alcoa

$21.70

-0.26 (-1.18%)

SCHN

Schnitzer Steel

$23.55

-0.27 (-1.13%)

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

19:08
09/22/19
09/22
19:08
09/22/19
19:08
Downgrade
Commercial Metals rating change at Goldman Sachs »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCHN

Schnitzer Steel

$23.55

-0.27 (-1.13%)

19:06
09/22/19
09/22
19:06
09/22/19
19:06
Downgrade
Schnitzer Steel rating change at Goldman Sachs »

Schnitzer Steel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNSR

Finisar

$24.31

1.25 (5.42%)

18:15
09/22/19
09/22
18:15
09/22/19
18:15
Hot Stocks
Finisar presents new products, technologies at ECOC 2019 »

Finisar introduced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNPQY

BNP Paribas

$0.00

(0.00%)

, DB

Deutsche Bank

$7.99

-0.08 (-0.99%)

18:04
09/22/19
09/22
18:04
09/22/19
18:04
Periodicals
Deutsche Bank nearing deal to transfer prime assets to BNP, Reuters says »

Deutsche Bank (DB) is…

BNPQY

BNP Paribas

$0.00

(0.00%)

DB

Deutsche Bank

$7.99

-0.08 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRSK

Verisk Analytics

$158.47

-0.21 (-0.13%)

18:00
09/22/19
09/22
18:00
09/22/19
18:00
Initiation
Verisk Analytics initiated at Keefe Bruyette »

Verisk Analytics assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.92

0.78 (2.10%)

, CMCSA

Comcast

$46.36

-0.32 (-0.69%)

16:58
09/22/19
09/22
16:58
09/22/19
16:58
On The Fly
Box Office Battle: 'Downton Abbey' wins weekend with $31M »

"Box Office Battle" is…

T

AT&T

$37.92

0.78 (2.10%)

CMCSA

Comcast

$46.36

-0.32 (-0.69%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$59.19

-0.19 (-0.32%)

LGF.A

Lionsgate

$9.49

-0.47 (-4.72%)

LGF.B

Lionsgate

$8.88

-0.435 (-4.67%)

DIS

Disney

$132.18

-1.14 (-0.86%)

VIAB

Viacom

$24.92

-0.28 (-1.11%)

VIA

Viacom

$26.67

-0.85 (-3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

VIVHY

Vivendi

$0.00

(0.00%)

, MDSO

Medidata

$91.77

-0.04 (-0.04%)

16:01
09/22/19
09/22
16:01
09/22/19
16:01
Periodicals
Vivendi to widen legal battle against Mediaset beyond Italy, Reuters says »

Vivendi (VIVHY) is taking…

VIVHY

Vivendi

$0.00

(0.00%)

MDSO

Medidata

$91.77

-0.04 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:57
09/22/19
09/22
15:57
09/22/19
15:57
Periodicals
Some WeWork board members seeing to remove Neumann as CEO, WSJ says »

A bloc of WeWork…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

15:54
09/22/19
09/22
15:54
09/22/19
15:54
Periodicals
SoftBank turns against WeWork's parent CEO, Reuters reports »

SoftBank (SFTBY), the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$24.92

-0.28 (-1.11%)

, VIA

Viacom

$26.67

-0.85 (-3.09%)

15:48
09/22/19
09/22
15:48
09/22/19
15:48
Hot Stocks
Viacom acquires exclusive cable rights to Seinfeld from Sony Pictures Television »

Viacom (VIAB, VIA)…

VIAB

Viacom

$24.92

-0.28 (-1.11%)

VIA

Viacom

$26.67

-0.85 (-3.09%)

SNE

Sony

$59.19

-0.19 (-0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Sep

  • 01

    Oct

  • 02

    Oct

  • 03

    Oct

PWR

Quanta Services

$37.61

-0.28 (-0.74%)

12:22
09/22/19
09/22
12:22
09/22/19
12:22
Conference/Events
Quanta Services management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

PTEN

Patterson-UTI

$9.66

0.01 (0.10%)

12:21
09/22/19
09/22
12:21
09/22/19
12:21
Conference/Events
Patterson-UTI management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ESE

Esco Technologies

$78.44

-1.54 (-1.93%)

12:19
09/22/19
09/22
12:19
09/22/19
12:19
Conference/Events
Esco Technologies management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

CSGP

CoStar Group

$595.10

-3.87 (-0.65%)

12:16
09/22/19
09/22
12:16
09/22/19
12:16
Conference/Events
CoStar Group participates in a conference call with Stephens »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 13

    Nov

CNNE

Cannae Holdings

$28.05

0.875 (3.22%)

12:02
09/22/19
09/22
12:02
09/22/19
12:02
Conference/Events
Cannae Holdings management to meet with Stephens »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.